Cirugía y Cirujanos

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board

>Journals >Cirugía y Cirujanos >Year 2009, Issue 5

Treviño-Becerra A
Tratamientos sustitutivos en enfermedad renal: diálisis peritoneal, hemodiálisis y trasplante renal
Cir Cir 2009; 77 (5)

Language: Español
References: 7
Page: 411-415
PDF: 67.82 Kb.

Full text


Chronic dialysis replacement treatments or renal transplants are instituted when the patient’s glomerular filtration rate, measured by 24-h urine endogenous creatinine clearance, is ‹10-15 ml/mm and, as the NKF-K/DOQI, European and Canadian guidelines point out, when one or two of the following complications occur: “uremic toxicity” symptoms, significant fluid retention that does not respond to loop diuretics, hyperkalemia, chronic anemia (hemoglobin ‹8 g), metabolic acidosis or acute pulmonary edema. In all patients for whom transplant is indicated, a selected live donor must be sought or, in the absence of contraindications, the patient should be registered with the national cadaver donation waiting list. While waiting for the transplant, patients will be on a chronic dialysis program. There is no national registry of patients undergoing chronic dialysis; only indirect data from the Mexican Kidney Foundation and the dialysis industry are available. However, it is estimated that 40,000-50,000 people are under this treatment and the numbers grow by 11% every year. Overall, it is thought that for every patient receiving chronic dialysis, there is one more patient who dies without access to therapy. Hemodialysis units must comply with the Official Hemodialysis Standard and the General Health Council Hemodialysis Unit Quality Assessment Form.

Key words: Chronic kidney disease, dialysis, transplantation.


  1. Zurita B, Zambrano M, Ramírez T, Villarreal E, Escobedo-de la Peña J, Rodríguez G, et al. Gasto en atención médica 2001. En: Muñoz O, Durán I, Garduño J, Soto H, eds. Seminario Internacional, Economía de la Salud. México: Instituto Mexicano del Seguro Social; 2003. pp. 115-124.

  2. Schettino MMA, Otero CF, Rodríguez RA, Aguilar MC, Barzalobre SA, Cardona ChJ, et al. Análisis comparativo de los costos en diálisis peritoneal y hemodiálisis en una unidad de tercer nivel. Nefrol Mex 1997;18:147-152.

  3. National Kidney Foundation. Kidney Disease Quality Initiative DOQI. Clinical Practice guidelines for chronic kidney disease: evaluation classification, and stratification. Part 5. Evaluation of laboratory measurements for clinical assessment of kidney disease. Am J Kidney Dis 2002;39(2 suppl 1):S76-S92.

  4. Cockroft DW, Gualt MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.

  5. Treviño BA. Enfermedad renal crónica y los diferentes tratamientos sustitutivos: diálisis peritoneal, hemodiálisis y trasplante renal. Vox Medica 2008;9(1-2 enero-febrero).

  6. Treviño BA. Insuficiencia renal crónica en México. Nefrol Mex 2002; 23(2):47.

  7. Peña JC. Transición y equilibrio de la diálisis peritoneal y la hemodiálisis en México en la próxima década. Memoria del II Foro Académico de la Insuficiencia Renal Crónica, Academia Nacional de Medicina. Nefrol Mex 2002;23:77-80.

>Journals >Cirugía y Cirujanos >Year 2009, Issue 5

· Journal Index 
· Links 

Copyright 2019